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Abstract  
The diagnosis of prostate cancer (PCa) often represents a stressful event. In addition to the 
psychological distress related to the diagnosis, patients face challenging health decisions: in fact, besides 
radical  treatments, Active Surveillance may represent an option for patients with diagnosis of localized 
PCa. A multidisciplinary clinical approach seems to represent the suitable organizational model to meet 
such a requirement, optimising the therapeutic outcome for PCa patients.The present study is a 
qualitative examination of the treatment decision-making process of men with a newly diagnosed 
localized PCa who received a multidisciplinary clinical consultation. Results suggest that a 
multidisciplinary approach may satisfy patients’ need to be comprehensively informed about all their 
chances and options of curing and managing the disease. Together with information, patients need to 
build a therapeutic relationship with the physicians in order to share their treatment decision-making 
experience. If this does not occur, frustration, confusion and other negative emotions may emerge. 
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1. Introduction 
The diagnosis of Prostate Cancer (PCa) represents a stressful event. In addition to the 
psychological distress related to the diagnosis, patients often face challenging health decisions 
in a context of great uncertainty. In fact, they unexpectedly deal with the opportunity/burden 
of choosing among multiple strategies that have comparable curative efficacy but differ in 
terms of clinical and personal costs and benefits (Cooperberg et al., 2011; Klotz et al. 2012; 
Heidenreich et al., 2014).  
For patients with clinically localized PCa, besides radical treatments (i.e., radical 
prostatectomy, external beam radiotherapy, brachytherapy, combined or not with hormonal 
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therapy), Active Surveillance (AS) may represent an option. Considering this scenario, high 
levels of decision-related distress at the time of diagnosis are common. A first step to support 
patients’ in overcoming decisional conflict consists in providing comprehensive and balanced 
information about the care process, the therapeutic options and all the relevant associated 
advantages and risks.  
A multidisciplinary (MD) clinical approach seems to represent the suitable organizational 
model to meet such a requirement, optimising the therapeutic outcome for PCa patients (Ko 
& Chaudhry, 2002; Kagan, 2005; Gomella, 2011; Aizer et al., 2012; Gomella, 2012). 
Despite the advantages of MD models have been acknowledged, their implementation is still 
facing a number of barriers from both an organizational and cultural perspective (Valdagni et 
al., 2011) and patients’ perception is still not evaluated (Lamb et al., 2013).  
With the aim of providing feedback and guidance to health care professionals, the current 
study intended to explore the treatment decision-making process of men with a newly 
diagnosed localized PCa who received an MD clinical consultation. 
 
2. Materials and method  
The present study is a qualitative examination of the treatment decision-making process of 
men with a newly diagnosed localized PCa who received an MD clinical consultation (the 
Prostate Cancer Unit at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan). Patients 
who had previously received  treatment for PCa or patients with a new diagnosis of locally 
advanced or metastatic cancer were excluded. During the MD visit (MDV) (Magnani et al., 
2012) patients contextually met a urologist, a radiation oncologist and a psychologist. 
 The physicians recorded the medical history, performed a digital rectal examination and 
informed the patients and their families about the feasible radical/observational options; a 
psychologist monitored the potential sources of psychological distress and presented the 
opportunity of a path of psychological counselling. At the end of the MDV, patients were 
informed about the decision-making study and invited to participate. Patients who accepted 
were immediately interviewed in a separate room, after they had signed an informed consent. 
Given the exploratory nature of the study a semi-structure interview was developed on the 
basis of the standard template from the Ottawa Decision Support Framework (O’Connor et 
al., 2011). As shown in Table 1, ten man (age range: 54-72, mean = 64.8, SD = 5.6 years) with 
localized PCa were interviewed by two psychologists with competencies both in 
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clinical/health and research psychology; the interview lasted 27 minutes on average (range 17-
40 minutes).   
They were recruited by theoretical sampling; this kind of sampling, regulated by the emerging 
theory, consists in identifying subjects following the indications coming from analysis process 
(Tarozzi, 2008), deepening the emerged dimensions step by step in order to verify the capacity 
in different contests; the enlargement of the sampling is interrupted when all the emerged 
categories are considered saturated, in this case after 10 interviews.  
 
Table 1. Demographic/clinical characteristics of the sample and therapeutic/observational 
options proposed before and at the MDV.  
ID Age Marital 
status 
Educational 
level 
Employment  Disease risk 
classification  
Therapeutic 
option 
suggested 
before the 
MDV1 
Therapeutic 
option 
suggested 
at the MDV 
ID 
1 
54 Divorced  Degree Entrepreneur LOW RP RP, EBRT, 
BT 
ID 
2 
69 Married High school 
diploma 
Employee LOW RP, EBRT RP, EBRT, 
BT, AS 
ID 
3 
58 Married Degree Entrepreneur  INTERMEDIATE RP, EBRT, 
BT, AS 
RP, EBRT, 
BT 
ID 
4 
66 Single High school 
diploma 
Employee LOW / RP, EBRT, 
BT, AS 
ID 
5 
70 Married Secondary 
school 
diploma 
Pensioner  HIGH FOR PSA / RP, 
EBRT+HT 
ID 
6 
64 Married High school 
diploma 
Entrepreneur LOW AS EBRT, AS 
ID 
7 
63 Married High school 
diploma 
Employee  INTERMEDIATE 
FOR PSA 
RP, EBRT, 
HIFU 
RP, EBRT 
ID 
8 
62 Married High school 
diploma 
Employee INTERMEDIATE RP RP, EBRT 
ID 
9 
72 Widower Primary 
school 
diploma 
Pensioner LOW AS EBRT, AS 
ID 
10 
69 Married Secondary 
school 
diploma 
Pensioner  LOW RP RP, EBRT, 
BT 
The Framework Analysis (Ritchie et al., 2013) was adopted to analyse the data. A paper-and-
pencil method was used to carry out the analysis following specific steps: a) transcription; b) 
familiarisation with the interviews; c) coding; d) identifying a thematic framework; e) applying 
the thematic framework; f) charting data into the framework matrix; g) interpreting the data. 
 
 
                                                 
1 RP = Radical Prostatectomy; EBRT = External Beam Radiotherapy; BT = Brachytherapy; AS = Active 
Surveillance; HIFU = High Intensity Focused Ultrasound; HT = Hormone Therapy   
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3. Results  
Based on the Framework Analysis, four central themes related to the patients’ needs were 
identified.  
Theme 1: “The comfort of MD setting”. Most patients described they benefited from the 
MDV in terms of received information from both a qualitative and quantitative perspective. 
The MDV contributed to clarify the characteristics of their disease, all the therapeutic options 
they could choose among (“Until this morning, we had not received any explanation about radiotherapy”; 
int. 3). Patients mostly perceived an improvement in the level of knowledge they had before 
accessing the visit. This perception contributed to generate pleasant emotions such as 
satisfaction, a sense of personal competence and relief (“When someone fully explained the situation, 
they allow you to make a decision that is the best for you. Maybe you could make a mistake, but you get wrong 
being well-informed of all the available options. So in a such case you say It’s ok!”; int.10.) 
Theme 2: “The disadvantage of MD setting”. The lack of congruence between the 
information that most patients received by previously consulted clinicians and the one they 
were given by the MD team contributed to complicate the individual decision-making process. 
Most interviewees attending the MDV were searching for a second consultation and often the 
information and treatment recommendations presented during the MDV were different from 
what they have received. Following this incongruence, interviewees often reported a feeling of 
confusion due to the difficulty of processing the new information ("I'm a little confused, 
bewildered. At first, I was a bit more keen on surgery, but I didn’t know about the third option yet, that is 
active surveillance, because other physicians hadn't recommended it! Only this time this option, I didn't think 
about, has emerged”; int. 3). 
Theme 3: “The lack of details”. This theme refers to a few unresolved questions about 
treatment procedures and related side effects that patients felt to still have at the end of the 
MDV. Some patients would have desired that physicians had provided them with more 
specific information about the side effects associated with each treatment. On the contrary 
such an expectation was not satisfied. From the patients’ point of view, this contributed to 
generate a feeling of uncertainty and increase the complexity of the decision-making process 
(“The information was not completely detailed, and therefore one cannot evaluate it, think about it and then 
ask further specifics”; int.10; “I’d like to have more objective data, a percentage of risk and benefits for each 
option. I know that nobody has the crystal ball, but tell me if there is fifty percent, thirty percent. You know, 
the numbers help you get an idea”, int.1). When discussing with the interviewees the issue of 
missing information, two prevalent kinds of arguments emerged. Some participants realised 
that they did not sufficiently engage during the MDV in the process of sharing their doubt or 
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questions with the medical team and played a passive role. Other men stressed that they would 
have liked more time to spend in discussing the provided information with the medical team. 
Time constraints were referred to as a limit of the MDV by some interviewees which 
prevented them from organizing the information in their mind and taking time to ask 
questions and clarify doubts.  
Theme 4: “The search for sharing”. This theme refers to the need of sharing their illness-
related experience and of feeling of support from others. An important role in the patient’s 
decision-making process was referred to be played by the spouses who were described as a 
source of both emotional and material (namely organizational) support (“My wife will be inclined 
for the solution that will have a higher percentage of success and will leave us a better quality of life. That's for 
sure!”, int.1). However, in some cases, the familiar support represented a distress factor for 
men. In fact, the way the partners reacted to their husband’s disease was sometimes reported 
to affect the men's mood negatively (“I don’t know which kind of support I could find in them  [...], 
given my wife has a particular character, I worry for her. She is vulnerable. Int.6).  
Patients also disclosed to consider the participation of the physicians in their decision-making 
process as paramount. Overall, the interviewees expressed the desire to feel in relation with 
the physicians and share with them the decisional process. (“People who are in our situation have a 
hundred questions and see the physician as a person who has the knowledge, who knows what can happen! 
They have expertise and more information than us. So they can give some advice”, int.1). 
 
4. Discussion 
The present study intended to explore the treatment decision-making process of men with a 
newly diagnosed localized PCa who received a clinical consultation within a MD cancer 
service. The results highlight the strengths and the limits of a MD context of care as well as 
the barriers to a shared choice according to the patients’ perspective. 
Communication with physicians both in terms of adequate and comprehensive information 
represents a milestone in patients’ decision-making process. Our results suggest that patients 
felt to benefit from the MDV in terms of being informed of all the available treatment 
options. The broad discussion regarding all the appropriate alternatives for managing their 
cancer contributed to reassure patients and create a greater feeling of hope about the chance 
of cure and the possibility of protecting their own quality of life. The presence of more 
specialists in the MDV was considered by the patients as a facilitating element of treatment 
decision-making since it enabled to overcome the drawback often related to the mono-
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specialist visit where physician tends to recommend the therapy within one’s speciality (Fowler 
et al., 2000; Hoffman et al., 2014).  
Patients recognized that being presented with a wider range of therapeutic options by the MD 
team was an opportunity. Nonetheless, they had difficulty processing new information due to 
a proactive interference effect (Jacoby et al., 2001) which required them some effort of being 
able to reduce the cognitive dissonance among contrasting information previously received 
(Festinger, 1957).  
Furthermore, the communication process was complicated in some cases by a lack of shared 
understanding of the clinical evidence; in fact clinicians usually consider risk information in 
terms of probabilities applicable to populations, not individual patients (Lipkus, 2007). On the 
other hand, patients’ understandings are idiosyncratic and based on subjective experiences or 
“common sense” which may determine an inappropriate use of health information 
(Kowalkowski et al., 2012; Coulter, 2010; Denberg et al., 2006; Birnie & Robinson, 2010). 
In this sense, a number of decisional aids (DAs) have been developed in order to provide clear 
and well structured information. External memory supports have been recommended as 
helpful to support physicians to address patients’ comprehension (Peters et al., 2008). 
Moreover, DAs aimed to help patients identify which questions they would like to be 
answered before accessing the medical consultation have been shown to be effective. They 
proved to increase both patients’ confidence to successfully make decisions and certainty that 
they had made the right decision (Hacking et al., 2013). In concordance with this, our MD 
group adopted a specific information booklet and ad hoc designed brochure reporting the 
details of what patients should expect from MDV (common needs, therapeutic options, 
research...).  
Nonetheless, we collected evidence that the information alone is not enough.  
Our interviewees showed not only do they want to be informed, rather to be guided in 
navigating the foreign territory of the disease (Rolland, 1999). Many interviewees emphasised a 
personal need, not completely met, of sharing their treatment decision-making experience with 
physicians and being engaged during the clinical encounter in a two-way communication 
process. The experience reported by our patients about their treatment decisional needs are 
consistent with the increasing consensus for a “shared decision-making approach” (Coulter & 
Collins, 2011) and suggest that encouraging participation may be the safest standard approach. 
Sharing the decision-making process means that patients and physicians work in partnership 
through a two-way exchange of information. They share the responsibility of both offering 
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and requesting information based on the assumptions that “it takes two to tango” (Charles et 
al., 1997). 
Studies showed that when patients make their decision about treatment in a context where the 
individual needs and preferences are at the centre of care they are also more likely to trust 
their clinicians (Keating et al., 2002) and more likely to adhere to treatment recommendations 
(Haynes et al., 2008), with a view to activate the patient engagement process, crucial 
component of high-quality healthcare services (Forbat et al., 2009). Specific decision support 
tools may facilitate shared decision-making, but alone they do not guarantee that it will occur. 
Shared decision-making may occur in a setting where patients are allowed and supported to 
have a more active role. If the physician is not motivated to share decision-making, the patient 
cannot force this to happen. Whether the clinician has a positive attitude toward a shared 
decision-making approach and prefers decision aids that engage in a shared decision-making 
process, patients become gradually confident in their ability to enrol in this process with them 
(Légaré & Thompson-Leduc, 2014). 
Patients often feel vulnerable and dependent in the relationship with physicians. (Roter, 1977; 
Roter, 1984; Kinnersley et al., 2008; Frosch et al., 2012; Henselmans et al., 2012). Clinicians’ 
attitude plays a crucial role in allowing the patient to gain self-confidence in asking questions, 
to feel listened, to be engaged in an open discussion where he can have an active role as far as 
managing their disease and, when necessary, to be helped to correct misconceptions or 
address any gaps in one's knowledge (Epstein & Street Jr, 2007). 
Up to now, the shared decision-making approach has been assessed mainly in mono-
specialized context. Very few studies on team-based approaches to shared decision-making 
have been conducted. Its implementation in a MD context could result extremely challenging 
given the number of different actors that are involved. Despite working in a MD group was 
reported to be advantageous as far as providing comprehensive information to the patients 
and their families, clinicians may be unfamiliar with establishing trust and granting an adequate 
amount of time to patients and their families in a MD setting (Bellardita et al., 2011) as well as 
conflicts about leadership may hinder the effectiveness of the team communication (Haward 
et al., 2003). Training on teamwork and leadership may be necessary to promote good 
communication among clinical team members and improve their effectiveness in building a 
relationship with patients in the MD setting. 
To our knowledge, this study is the first to explore the met and unmet treatment decision-
making needs of patients with PCa accessing a MD cancer service. Particularly, our data 
suggest that a MD approach may satisfy patients’ need to be comprehensively informed about 
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all their chances of curing and managing the disease. Together with information, patients need 
to build a therapeutic relationship with the physicians in order to share their treatment 
decision-making experience. If this does not occur, frustration, confusion and other negative 
emotions may emerge.  
The identification of met and unmet needs may be useful in facilitating future planning of MD 
setting from an organizational perspective, including educational and psychological support 
interventions. Shared decision-making approach had to be further accepted and implemented 
and specific training to physicians may be necessary.  
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